Oragenics Inc (OGEN)
1.050
+0.03
(+2.95%)
USD |
NYAM |
May 02, 16:00
1.055
0.00 (0.00%)
After-Hours: 20:00
Oragenics Cash from Investing (Quarterly): -1.00M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.00M |
September 30, 2023 | 0.0637M |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | -0.0034M |
September 30, 2022 | -0.037M |
June 30, 2022 | 0.00 |
March 31, 2022 | -0.075M |
December 31, 2021 | -0.0198M |
September 30, 2021 | -0.0241M |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 |
Date | Value |
---|---|
December 31, 2019 | -0.0139M |
September 30, 2019 | 0.00 |
June 30, 2019 | -0.0114M |
March 31, 2019 | |
December 31, 2018 | -0.0645M |
September 30, 2018 | -0.0602M |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.425M |
June 30, 2016 | 1.25M |
March 31, 2016 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.00M
Minimum
Dec 2023
0.0637M
Maximum
Sep 2023
-0.0701M
Average
-0.0017M
Median
Cash from Investing (Quarterly) Benchmarks
Palatin Technologies Inc | 9.462M |
Inogen Inc | 4.128M |
Cyclacel Pharmaceuticals Inc | 0.00 |
Actinium Pharmaceuticals Inc | -0.011M |
MAIA Biotechnology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.102M |
Cash from Financing (Quarterly) | -0.1806M |
Free Cash Flow | -7.291M |
Free Cash Flow Per Share (Quarterly) | -0.4257 |
Free Cash Flow Yield | -308.7% |